Evidence-based Management of Sickle Cell Disease (Paperback) (ISBN-13: 9781502452788)

These guidelines were developed by an expert panel composed of health care professionals with expertise in family medicine, general internal medicine, adult and pediatric hematology, psychiatry, transfusion medicine, obstetrics and gynecology, emergency department nursing, and evidence-based medicine. Panel members were selected by the National Heart, Lung, and Blood Institute's (NHLBI's) leadership. The purpose of these guidelines is to help people living with sickle cell disease (SCD) receive appropriate care by providing the best science-based recommendations to guide practice decisions. The target audience is primary care providers and other clinicians, nurses, and staff who provide emergency or continuity care to individuals with SCD. NHLBI sponsored the development of these guidelines to assist health care professionals in the management of common issues, including routine health maintenance, the recognition and treatment of common acute and chronic complications and comorbidities of SCD, as well as the indications for and monitoring of hydroxyurea and blood transfusion therapy. The guidelines address the care of infants, children, adolescents, and adults with SCD, with the goal of facilitating high-quality and appropriate care for all individuals with this disease. Professional Associations that endorse these guidelines: Academy of Emergency Medicine (AAEM) American Academy of Pediatrics (AAP) American Academy of Physician Assistants (AAPA) American Osteopathic Association (AOA) American Society of Hematology (ASH) American Society of Pediatric Hematology/Oncology (ASPHO) International Association of Sickle Cell Nurses and Physician Assistants (IASCNAPA) National Black Nurses Association (NBNA) National Initiative for Children's Health Quality (NICHQ) National Medical Association (NMA) Sickle Cell Disease Association of America (SCDAA)